What is the recommended peri‑operative management for an emergency foot wound debridement in a patient who had a cerebrovascular accident (stroke) less than one month ago (ASA IV) and is on low‑dose aspirin (81 mg daily) with possible clopidogrel, warfarin, or heparin therapy?

Emergency Foot Wound Debridement in Recent Stroke Patient on Antiplatelet/Anticoagulation

Continue aspirin (81 mg daily) throughout the perioperative period for this emergency foot wound debridement, given the recent stroke (<1 month ago). For patients on clopidogrel or aspirin for secondary stroke prevention, especially after a recent stroke, aspirin should be continued through the perioperative period 1. The thrombotic risk of recurrent stroke in this ASA IV patient with recent cerebrovascular accident far outweighs the bleeding risk of a foot debridement procedure.

Aspirin Management

• Continue aspirin 81 mg daily without interruption 2, 3, 2
• Aspirin (81-325 mg daily) is recommended before and may be continued indefinitely in stroke patients 2
• For patients with cardiac risk factors on low-dose aspirin alone, this can be continued perioperatively without increased risk of major bleeding 1
• The 2011 ASA/ACCF/AHA stroke guidelines explicitly state aspirin should be continued in the perioperative setting for secondary stroke prevention 2, 3

Clopidogrel Management (if applicable)

If the patient is on dual antiplatelet therapy (aspirin + clopidogrel):

• Continue aspirin, stop clopidogrel 5 days before surgery 1
• Neurological consultation is strongly recommended to evaluate competing risks and determine necessity for bridging therapy 1
• Withdrawal of dual antiplatelet therapy should NOT occur within 12 months of drug-eluting stent placement or 3 months of bare metal stent placement 1
• Given the recent stroke (<1 month), the thrombotic risk is extremely high, making this a critical decision requiring multidisciplinary input

Warfarin Management (if applicable)

If on warfarin:

• Stop warfarin 3-5 days before surgery 4
• Target INR <1.5 before proceeding 1
• Bridge with therapeutic-dose LMWH or unfractionated heparin given the high stroke risk from recent CVA 5
  • LMWH: enoxaparin 1 mg/kg BID or 1.5 mg/kg daily 5
  • UFH: target aPTT 1.5-2 times control 5, 6
• Last dose of LMWH should be given 24 hours before surgery 5
• Continue aspirin throughout 1
• Resume warfarin 12-24 hours postoperatively if bleeding risk acceptable 1

Novel Oral Anticoagulants (NOACs) Management (if applicable)

If on dabigatran, rivaroxaban, or apixaban:

• For emergency procedures, consultation with cardiology/hematology is strongly advised 1
• Ideally delay procedure 24-36 hours if possible to allow expert consultation 1
• NOACs should be discontinued 2-5 days before elective surgery depending on bleeding risk 1
• Bridging with heparin is recommended to prevent acute stroke risk 1
• Continue aspirin throughout 1

Critical Timing Considerations

The <1 month timeframe since stroke is crucial:

• Patients with recent stroke (<1 month) have the highest risk of recurrent stroke perioperatively 7, 8, 9
• The 2011 stroke guidelines recommend intervention within 2 weeks of index stroke event when revascularization is indicated, acknowledging the high early recurrence risk 2
• Emergency surgery in this window requires extreme caution with antiplatelet/anticoagulation management 10, 11

Procedure-Specific Risk Assessment

Foot wound debridement is generally considered intermediate bleeding risk:

• Not a closed cavity procedure
• Operative site is accessible for local hemostasis
• Can typically proceed safely on aspirin alone 1
• If dual antiplatelet therapy is necessary, the limited surgical field allows for effective local hemostatic measures 3

Postoperative Management

• Resume full anticoagulation as soon as hemostasis is secure, typically 12-24 hours postoperatively 1, 4
• Monitor closely for both bleeding complications and neurological changes
• Document neurological examination within 24 hours before and after procedure 2, 3, 2
• Blood pressure control is critical perioperatively 2, 3, 2

Key Pitfalls to Avoid

1. Do NOT stop aspirin in this recent stroke patient—the thrombotic risk is prohibitive 1
2. Do NOT proceed without neurological consultation if on dual antiplatelet therapy 1
3. Do NOT use prophylactic-dose heparin for bridging—therapeutic dosing is required for stroke prevention 5
4. Do NOT delay resumption of anticoagulation unnecessarily postoperatively—the stroke risk remains elevated 1